Similar drugsTo uncover Dosage form: & nbspnasal drops Composition: Active substance: concentrate "RUZAM®" (extract from the culture thermophilic strain of Staphylococcus aureus (Staphylococcus aureus, PC.C-2) 0.02 mg to 0.04 mg. Excipients: phenol 0.3 mg, sodium chloride solution for injections of 0.9% to 1 ml. Description:Transparent or slightly colored liquid with a slight smell of phenol. Pharmacotherapeutic group:Antiallergic agent ATX: & nbspOther immunostimulants Pharmacodynamics: Has anti-inflammatory and anti-allergic effect. Reduces the edema of the mucous membrane of the respiratory tract, reduces the content of eosinophils and mast cells in the focus of inflammation. Increases the level secretory immunoglobulin class A, which increases the resistance of the mucosa to infection. Indications: - Seasonal and all-the-year-round allergic rhinitis. Contraindications: - Hypersensitivity to the drug; - pregnancy; - children under 3 years; - acute infection; - tuberculosis (active form); - decompensated diseases of internal organs. Pregnancy and lactation: There is insufficient data on the potential for teratogenic or toxic effects on the fetus during pregnancy, so the use of the drug during pregnancy is not recommended. The use of the drug during breast-feeding is not recommended. Dosing and Administration: Intranasally. Prescribe to children at the age of 3 to 12 years 1-2 drops of the drug 1-2 times a day in each nasal passage for 2 weeks, adults and children over the age of 12 2-3 drops of the drug 2- 3 times a day in each nasal passage. The course of treatment for year-round rhinitis 2-4 weeks, if necessary, repeat the course after 1 -2 months. With pollinosis, start treatment one week before flowering and continue during the flowering period of 2-3 weeks. Side effects: Headache, weakness, dryness in the nose, malaise and exacerbation of the focus of chronic infection of the ENT organs. Overdose: No cases of overdose have been reported. Interaction: Cases of negative interaction with other drugs are unknown. Special instructions: At the beginning of treatment, there may be an increase in rhinorrhea, perhaps in rare cases, an exacerbation of the focus of a chronic infection in the nasopharynx. These symptoms pass on their own and do not require withdrawal of the drug. Effect on the ability to drive transp. cf. and fur: The use of the drug RUZAM® does not affect the psychomotor functions associated with the driving of vehicles or the management of machines and mechanisms. Form release / dosage:The drops are nasal. Packaging: 5 ml of the drug in a vial. One bottle is included with a dropper with a cap or a dropper cap with instructions for use in a pack of cardboard box. Storage conditions: The preparation is stored and transported in accordance with "SP 3.3.2.3332-16", at a temperature of 4 to 20 ° C. Keep out of the reach of children. Shelf life: 4 of the year. Do not use after the expiration date printed on the package. Terms of leave from pharmacies:Without recipe Registration number:LP-004309 Date of registration:24.05.2017 Expiration Date:24.05.2022 The owner of the registration certificate:RUZAM-M, LLC RUZAM-M, LLC Russia Manufacturer: & nbspRUZAM-M, LLC Russia Information update date: & nbsp22.06.2017 Illustrated instructions × Illustrated instructions Instructions